# Prospective Electronic Polygenic Risk Study - Second Phase

> **NCT05175651** · NA · NOT_YET_RECRUITING · sponsor: **Scripps Translational Science Institute** · enrollment: 10000 (estimated)

## Conditions studied

- Coronary Artery Disease
- Glaucoma

## Interventions

- **BEHAVIORAL:** Genetic risk assessment

## Key facts

- **NCT ID:** NCT05175651
- **Lead sponsor:** Scripps Translational Science Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06
- **Primary completion:** 2025-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2022-11-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175651, "Prospective Electronic Polygenic Risk Study - Second Phase". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05175651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*